In vitro bactericidal activity of jinghua weikang capsule (荆花胃康胶丸) and its individual herb Chenopodium Ambrosioides L. against antibiotic-resistant Helicobacter Pylori

Wei Liu; Yu Liu; Xue-zhi Zhang; Ning Li; Hong Cheng

doi:10.1007/s11655-012-1248-y

Your Location：

Home >

Browse articles >

In vitro bactericidal activity of jinghua weikang capsule (荆花胃康胶丸) and its individual herb Chenopodium Ambrosioides L. against antibiotic-resistant Helicobacter Pylori

OriginalPaper | Updated：2021-08-27

- In vitro bactericidal activity of jinghua weikang capsule (荆花胃康胶丸) and its individual herb Chenopodium Ambrosioides L. against antibiotic-resistant Helicobacter Pylori
- In vitro bactericidal activity of jinghua weikang capsule (荆花胃康胶丸) and its individual herb Chenopodium Ambrosioides L. against antibiotic-resistant Helicobacter Pylori
- 中国结合医学杂志（英文版） 2013年19卷第1期页码：54-57
- Affiliations：
  
  1. Department of Tradional Chinese Medicine and Integrated Tradional Chinese and Western Medicine, Peking University First Hospital,Beijing,China
  2. Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Beijing,China
  3. Department of Gastroenterology, Peking University First Hospital,Beijing,China
- Author bio：
- Funds：
  
  Supported by Capital Medical Development and Research Foundation (No. SF-2007-III-01) and National Natural Science Foundation of China (No. 8107295);These authors contributed equally to this work
- DOI：10.1007/s11655-012-1248-y
  中图分类号：
- 纸质出版日期：2013，
  
  网络出版日期：2012-12-29，
Scan for full text
Liu, W., Liu, Y., Zhang, Xz. et al. , In vitro bactericidal activity of jinghua weikang capsule (荆花胃康胶丸) and its individual herb Chenopodium Ambrosioides L. against antibiotic-resistant Helicobacter Pylori, ., Chin. J. Integr. Med. 19, 54–57 (2013). https://doi.org/10.1007/s11655-012-1248-y

Wei Liu, Yu Liu, Xue-zhi Zhang, et al. In vitro bactericidal activity of jinghua weikang capsule (荆花胃康胶丸) and its individual herb Chenopodium Ambrosioides L. against antibiotic-resistant Helicobacter Pylori[J]. Chinese Journal of Integrative Medicine, 2013,19(1):54-57.
Liu, W., Liu, Y., Zhang, Xz. et al. , In vitro bactericidal activity of jinghua weikang capsule (荆花胃康胶丸) and its individual herb Chenopodium Ambrosioides L. against antibiotic-resistant Helicobacter Pylori, ., Chin. J. Integr. Med. 19, 54–57 (2013). https://doi.org/10.1007/s11655-012-1248-y DOI：

Wei Liu, Yu Liu, Xue-zhi Zhang, et al. In vitro bactericidal activity of jinghua weikang capsule (荆花胃康胶丸) and its individual herb Chenopodium Ambrosioides L. against antibiotic-resistant Helicobacter Pylori[J]. Chinese Journal of Integrative Medicine, 2013,19(1):54-57. DOI： 10.1007/s11655-012-1248-y.

摘要

To investigate the bactericidal effects of Jinghua Weikang Capsule (荆花胃康胶丸) and its major component Chenopodium ambrosioides L. on antibiotic-resistant Helicobacter pylori. Four clinical antibiotic-resistant H. pylori strains were isolated and incubated in liquid medium containing Jinghua Weikang Capsule or Chenopodium ambrosioides L. By means of time-kill curve method

the average colony counts and bactericidal rate were calculated at time points of 0

8 and 24 h after the incubation and the time-kill curves were charted. Both Jinghua Weikang Capsule and Chenopodium ambrosioides L. at a concentration of 0.64 g/L showed obvious bactericidal effect against antibiotic-resistant H. pylori after 4 h of incubation. Jinghua Weikang Capsule and Chenopodium ambrosioides L. are considered to be active against antibiotic-resistant H. pylori in vitro.

Abstract

the average colony counts and bactericidal rate were calculated at time points of 0

关键词

Helicobacter pyloriJinghua Weikang CapsuleChenopodium ambrosioides L.antibioticresistancebactericidal activityChinese Medicine

Keywords

Helicobacter pyloriJinghua Weikang CapsuleChenopodium ambrosioides L.antibioticresistancebactericidal activityChinese Medicine

references

Miwa H, Sakaki N, Sugano K, Sekine H, Higuchi K, Uemura N, et al. Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients. Helicobacter 2004;9:9–16.

Nervi G, Liatopoulou S, Cavallaro LG, Gnocchi A, Dal-Bo N, Rugge M, et al. Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? A 10 years’ endoscopical survey. World J Gastroenterol 2006;12:2398–2401.

Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 2004;53:34–37.

Konturek PC, Konturek SJ, Brzozowski T. Helicobacter pylori infection in gastric cancerogenesis. J Physiol Pharmacol 2009;60:3–21.

Huang XT, Zhang XZ, Li N, Cheng H. In vitro activity of Jinghuaweikang capsules against clinical isolates of antibiotic-resistant Helicobacter pylori. Chin J Integr Tradit West Med Dig (Chin) 2010;18:290–293.

Zhang WD, Hu FL, Xiao SD, Xu ZM. Prevalence of Helicobacter pylori infection in China. Modern Dig Intervent (Chin) 2010;15:265–270.

Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a highrisk region of China: a randomized controlled trial. JAMA 2004;291:187–194.

Liang X, Liu WZ, Lu H, Xu WW, Xiao SD. Helicobacter pylori: in vitro induction of resistance to antibiotics and surveillance of its resistant prevalence. Chin J Dig Dis (Chin) 2003;23:146–149.

Federman DG, Kirsner RS, Moriarty JP, Concato J. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol 2003;49:861–864.

Mégraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004;53:1374–1384.

Cheng H, Hu FL, Xie Y, Hu PJ, Wang JY, Lv NH, et al. Chinese Helicobacter Pylori Research Group, Chinese Society of Gastroenterology. Prevalence of Helicobacter pylori resistance to antibiotics and its influence on the treatment outcome in China: a multicenter clinical study. Chin J Gastroenterol (Chin) 2007;12:525–530.

Cao CY, Shan YJ, Li SC, Jin H, Tang HW. The antibioticresistance analysis of 200 Helicobacter pylori isolates. Zhejiang Prev Med (Chin) 2008;20:21–23.

Li XR, Li FQ, Xue YC, Shi DX, Ma J. Current status of the essential oil extraction process of Chinese medicine. Chin J Manag Chin Med (Chin) 2006;14:66–67.

Dou Y, Wang XD, Liang H, Liu SJ, Dong SH, Wang J. Comparison of the efficacy and safety of Jinghua Weikang Capsules and famotidine in treatment of Hp related peptic ulcer. Chin J New Drugs (Chin) 2004;13:650–652.

Jiang HQ, Zhang RX, Lu XP, Liu GF. Clinical observation of Jinghua Weikang therapy in patients with chronic gastritis. Tianjin Phamacy (Chin) 2004;16:31–33.

Zhang BF, Han YS, Yang J. Clinical observation of Jinghua Weikang Capsule in patients with peptic ulcer. Tianjin J Tradit Chin Med (Chin) 2004;21:201.

Miu H. Observation of effects of Jinghua Weikang Capsules on chronic gastritis and eradication of Helicobacteria pylori. Clin J Med Offic (Chin) 2010;38:563–564.

Fan Z, Wen Q. Effect of Jinghua Weikang Capsules on gastric ulcers. Chin Gen Pract (Chin) 2009;12:429–430.

FULL TEXT LINK

More>

浏览量

926

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture

Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients

Objective tongue inspection on 142 liver cancer patients with damp-heat syndrome

Effect of Ermiao Recipe (二妙方) with medicinal guide Angelicae Pubescentis Radix on promoting the homing of bone marrow stem cells to treat cartilage damage in osteoarthritis rats

Effects of Jianpi Jiedu Recipe (健脾解毒方) on reversion of P-glycoprotein-mediated multidrug resistance through COX-2 pathway in colorectal cancer